Table 2.
Characteristics of study patients according to SSRI use.
| SSRI Use |
|||
|---|---|---|---|
| Total (n = 497) | No: n = 346 (69.6%) | Yes: n = 151 (30.4%) | |
| Age (years)a | |||
| Mean (SD) | 59.3 (14.0) | 59.1 (14.0) | 59.7 (13.9) |
| Sex | |||
| Male | 299 (60.2%) | 216 (62.4%) | 83 (55.0%) |
| Female | 198 (39.8%) | 130 (37.6%) | 68 (45.0%) |
| Race | |||
| White | 366 (73.6%) | 249 (72.0%) | 117 (77.5%) |
| Asian | 9 (1.8%) | 6 (1.7%) | 3 (2.0%) |
| Black | 26 (5.2%) | 20 (5.8%) | 6 (4.0%) |
| Other | 47 (9.5%) | 37 (10.7%) | 10 (6.6%) |
| Declined | 49 (9.9%) | 34 (9.8%) | 15 (9.9%) |
| Operation | |||
| Biopsy | 86 (17.3%) | 71 (20.5%) | 15 (9.9%) |
| Resection | 411 (82.7%) | 275 (79.5%) | 136 (90.1%) |
| CCI Scoreb | |||
| 0 | 384 (77.3%) | 272 (78.6%) | 112 (74.2%) |
| 1 | 66 (13.3%) | 40 (11.6%) | 26 (17.2%) |
| 2 | 28 (5.6%) | 20 (5.8%) | 8 (5.3%) |
| 3+ | 19 (3.8%) | 14 (4.0%) | 5 (3.3%) |
a
Age at diagnosis of GBM.
b
CCI = Charlson Comorbidity Index.